BATS:HELX Franklin Genomic Advancements ETF (HELX) Price, Holdings, & News → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free HELX Stock Alerts $31.30 -0.25 (-0.79%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$31.30▼$31.4650-Day Range$29.32▼$32.9252-Week Range N/AVolume138 shsAverage VolumeN/AMarket Capitalization$9.39 millionAssets Under Management$9.47 millionDividend YieldN/ANet Expense Ratio0.50% Stock AnalysisStock AnalysisChartHoldingsRatingsStock AnalysisChartHoldingsRatings Get Franklin Genomic Advancements ETF alerts: Email Address About Franklin Genomic Advancements ETFThe Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that is based on the Solactive Genomics index. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is managed by Franklin Templeton.Read More HELX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HELX ETF News HeadlinesApril 23, 2024 | lse.co.ukFranklin Catholic Princ Em Sov Ucits Etf Share Price (CATHEM.MI)March 27, 2024 | money.usnews.comFranklin U.S. Treasury Bond ETFNovember 25, 2023 | lse.co.ukFranklin Msci China Paris Alig Ucits Etf Share Price (FRCP.MI)November 17, 2023 | lse.co.ukFranklin Emerging Markets Ucits Etf Share Price (FLXE.MI)February 25, 2023 | morningstar.comBMO ARK Genomic Revolution ETF SeriesSee More Headlines Receive HELX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Franklin Genomic Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address Fund Details IssuerFranklin Templeton Investments Fund NameFranklin Genomic Advancements ETF Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:HELX Inception Date2/25/2020 Fund ManagerMatthew J.Moberg, Joyce Lin WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings63 Fund Statistics Assets Under Management$9.47 million Average Daily Volume$0.00 Discount/Premium-0.02% Administrator, Advisor and Custodian AdministratorFranklin Templeton Services, LLC AdvisorFranklin Advisers, Inc. CustodianState Street Bank and Trust Company DistributorFranklin Templeton Distributors, Inc. Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerCitadel Miscellaneous Outstanding Shares300,000Beta1.00 Creation Unit50,000 Creation Fee$200.00 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Ad WealthPressThe Tesla Indicator Is BullishIf you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward…>> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo Franklin Genomic Advancements ETF ExpensesTypeHELXTheme ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.50%0.57%0.54%0.56%0.51%Other Expenses0.00%0.72%0.54%0.51%0.58%Total Expense0.50%0.72%0.70%0.68%0.70%Fee Waiver0.00%-0.76%-0.55%-0.34%-0.56%Net Expense0.50%0.59%0.60%0.63%0.58% Franklin Genomic Advancements ETF (HELX) Holdings & ExposureTop 10 HELX HoldingsMedpace(NASDAQ:MEDP)Holding Weight: 6.85%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 5.33%Danaher(NYSE:DHR)Holding Weight: 5.15%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 5.01%Thermo Fisher Scientific(NYSE:TMO)Holding Weight: 4.92%Eli Lilly and Company(NYSE:LLY)Holding Weight: 4.46%Krystal Biotech(NASDAQ:KRYS)Holding Weight: 4.00%Natera(NASDAQ:NTRA)Holding Weight: 3.40%Moderna(NASDAQ:MRNA)Holding Weight: 3.07%Samsung BioLogics Co LtdHolding Weight: 2.91%HELX Sector ExposureHELX Industry ExposureFull Holdings Details Similar ETFsB.A.D. EtfNYSEARCA:BADInvesco Electric Vehicle Metals Commodity Strategy No K-1 ETFNASDAQ:EVMTInvesco Alerian Galaxy Crypto Economy ETFBATS:SATOIQ Healthy Hearts ETFNYSEARCA:HARTDirexion Daily Travel & Vacation Bull 2X SharesNYSEARCA:OOTO HELX ETF - Frequently Asked Questions How have HELX shares performed in 2024? Franklin Genomic Advancements ETF's stock was trading at $30.47 at the beginning of 2024. Since then, HELX shares have increased by 2.7% and is now trading at $31.2980. View the best growth stocks for 2024 here. What does HELX invest in? Franklin Genomic Advancements ETF is a equity fund issued by Franklin Templeton Investments. HELX focuses on theme investments. The fund's investments total to approximately $9.47 million assets under management. What stocks does Franklin Genomic Advancements ETF hold? HELX invests in 63 holdings. Some of the stocks in their portfolio include Medpace (MEDP), Vertex Pharmaceuticals (VRTX), Danaher (DHR), Regeneron Pharmaceuticals (REGN), Thermo Fisher Scientific (TMO), Eli Lilly and Company (LLY), Krystal Biotech (KRYS), Natera (NTRA), Moderna (MRNA) and Bruker (BRKR). What is the management fee for Franklin Genomic Advancements ETF? Franklin Genomic Advancements ETF's management fee is 0.50% and has no other recorded expenses or fee waivers. The net expense ratio for HELX is 0.50%. How do I buy shares of Franklin Genomic Advancements ETF? Shares of HELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (BATS:HELX) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersA once-in-a-century investment opportunityStansberry ResearchWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.